← Open Payments lookup

KAZEEM OLAJIDE: Open Payments

NPI 1184110165 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$288 in 15 payments from 5 companies in 2025. Trend: 2023 $140 · 2024 $220 · 2025 $288

Food & beverage: $288
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$90
Teva Pharmaceuticals USA, Inc.5$90
Alkermes, Inc.3$53
E.R. Squibb & Sons, L.L.C.2$37
ABBVIE INC.1$17

Products named: INGREZZA, AUSTEDO XR, COBENFY, ARISTADA, VIVITROL, VRAYLAR.

Industry payments across NJ — which companies pay providers there.